Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.50 |
| ▸ | PTAFR | P25105 | 1/20 | 0.50 |
| ▸ | HTR1D | P28221 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.46 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | AKT1 | P31749 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18140498 | 0.86 | TSHR (0.42) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL18141361 | 0.86 | TSHR (0.42) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| Lithium Ion SCHEMBL18139734 | 0.86 | TSHR (0.42) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL18139362 | 0.86 | TSHR (0.42) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| Potassium Ion SCHEMBL18139644 | 0.86 | TSHR (0.42) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL428693 | 0.86 | SMN1; SMN2 (0.52) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL28853370 | 0.85 | FABP3 (0.45) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL1260662 | 0.85 | ADRA1D (0.57) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL529986 | 0.84 | SMN1; SMN2 (0.46) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL1260814 | 0.83 | ADRA1D (0.57) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084739-B2 | Cross-linked copolymer containing phosphorylcholine monomer and cosmetic composition containing same | KCI LIMITED (KR) | 2015-07-21 | — | — | US | claimed |
| US-20140288259-A1 | SURFACE-MODIFIED ULTRAVIOLET BLOCKING POWDER AND ULTRAVIOLET BLOCKING COMPOSITION INCLUDING SAME | KCI CO., LTD. (KR) | 2014-09-25 | — | — | US | claimed |
| EP-2662070-A2 | CROSS-LINKED COPOLYMER CONTAINING PHOSPHORYLCHOLINE MONOMER AND COSMETIC COMPOSITION CONTAINING SAME | KCI Limited. (KR) | 2013-11-13 | — | — | EP | claimed |
| US-20130295038-A1 | Cross-Linked Copolymer Containing Phosphorylcholine Monomer and Cosmetic Composition Containing Same | KCI LIMITED (KR) | 2013-11-07 | — | — | US | claimed |
| US-8278097-B2 | Method for forming embryoid bodies | NOF CORPORATION (JP) | 2012-10-02 | — | — | US | claimed |
| US-20090246871-A1 | For forming embryoid bodies from embryonic stem (ES) cells easily and efficiently without complicated technique | NOF CORPORATION (JP) | 2009-10-01 | — | — | US | claimed |
| US-20060252148-A1 | For forming embryoid bodies from embryonic stem (ES) cells easily and efficiently without complicated technique | NOF CORPORATION (JP) | 2006-11-09 | — | — | US | claimed |
| EP-0537972-B1 | Treating solution for contact lenses | NOF CORP (JP) | 1996-07-10 | — | — | EP | claimed |
| US-5461433-A | Cleaning contact lens by immersing in solution containing copolymer where one of the monomers contains phsophate and tertiary ammonium groups | NOF CORPORATION (JP) | 1995-10-24 | — | — | US | claimed |
| EP-0537972-A1 | Treating solution for contact lenses | NOF CORPORATION (JP) | 1993-04-21 | — | — | EP | claimed |
| US-20240092043-A1 | CONTACT LENS WITH A HYDROGEL COATING THEREON | ALCON INC. (CH) | 2024-03-21 | — | — | US | disclosed |
| EP-3896074-B1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | AIST (JP) | 2023-10-25 | — | — | EP | disclosed |
| US-20220017648-A1 | Method, Kit, and Device for Preparing Glycan from Glycoprotein | SUMITOMO BAKELITE CO., LTD. (JP) | 2022-01-20 | — | — | US | disclosed |
| EP-3896074-A1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-10-20 | — | — | EP | disclosed |
| US-11136344-B2 | Purification agent for sugar chain or glycopeptide, and use thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| US-20060252148-A1 | For forming embryoid bodies from embryonic stem (ES) cells easily and efficiently without complicated technique | NOF CORPORATION (JP) | 2006-11-09 | — | — | US | disclosed |
| EP-1657302-A1 | CONTAINER FOR GERM LAYER FORMATION AND METHOD OF FORMING GERM LAYER | NOF CORPORATION (JP) | 2006-05-17 | — | — | EP | disclosed |
| EP-0537972-B1 | Treating solution for contact lenses | NOF CORP (JP) | 1996-07-10 | — | — | EP | disclosed |
| US-5461433-A | Cleaning contact lens by immersing in solution containing copolymer where one of the monomers contains phsophate and tertiary ammonium groups | NOF CORPORATION (JP) | 1995-10-24 | — | — | US | disclosed |
| EP-0537972-A1 | Treating solution for contact lenses | NOF CORPORATION (JP) | 1993-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288259-A1 | SURFACE-MODIFIED ULTRAVIOLET BLOCKING POWDER AND ULTRAVIOLET BLOCKING COMPOSITION INCLUDING SAME | C1QBP, PCTP, CD59 | SMN1; SMN2 4469/4885ADRA1D 2687/4885PTAFR 851/4885 |
| US-20130295038-A1 | Cross-Linked Copolymer Containing Phosphorylcholine Monomer and Cosmetic Composition Containing Same | PHOSPHO1, SGMS1, SGMS2 | SMN1; SMN2 2864/4885ADRA1D 2549/4885PTAFR 1310/4885 |
| US-11136344-B2 | Purification agent for sugar chain or glycopeptide, and use thereof | FUT5, MANBA, MGAM | SMN1; SMN2 3076/4885ADRA1D 3137/4885PTAFR 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.